A randomized comparison of comprehensive weight loss intervention vs. usual care on recurrences of atrial fibrillation in obese patients after catheter ablation: HOBIT-AF trial
Europace · 04.11.2026 · 28 (11)
DOI: 10.1093/europace/euag178 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Europace, online erschienen am 04.11.2026. Verfasst von Kristýna Koščálová und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Vídeňská 1958/9, Prague 4 140 21, Czechia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Obesity, Weight Loss. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agency for Health Research, Ministry of Health of the Czech Republic.
Abstract (Originalsprache)
Aims
Obesity is one of the strongest risk factors for the development of atrial fibrillation (AF), and its reduction is associated with the alleviation of AF burden. The HOBIT-AF study aimed to evaluate the impact of complex weight loss interventions on AF recurrence rate in obese individuals after catheter ablation (CA). Methods and results The HOBIT-AF was a randomized controlled trial with a 15-month treatment period (3–18 months post CA) involving complex weight-reducing interventions in the active arm. The primary outcome was the change in AF/atrial tachycardia (AT) burden assessed from baseline and the final 14-day Holter monitoring. A total of 167 individuals (aged 59 years, body mass index of 35.6 kg/m2) were randomized into the active (n = 85) and control group (n = 82). At the end of the treatment period, a mean reduction of 6.8 ± 7.0% of the initial body weight accompanied by improvement of metabolic parameters was achieved in the active group. The AF/AT burden change was 0.6 ± 2.5% (95% CI: −4.2–5.5%) in the active group and −0.9 ± 1.8% (95% CI: −4.5–3.0%) in the control group. The AF/AT recurrence-free survival during the 3–18-month follow-up period was comparable between groups (70.4% vs. 69.6%).
Conclusion
HOBIT-AF trial showed that despite the beneficial effect of body weight reduction on metabolic profile of obese patients with predominantly paroxysmal AF after CA, no reduction in AF/AT recurrence was observed in comparison with control patients. This may be likely due to low AF burden after previous CA, limiting further improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Vídeňská 1958/9, Prague 4 140 21, Czechia.
- Third Faculty of Medicine, Charles University, Ruská 87, Prague 10 100 00, Czechia.
- Diabetes Centre, IKEM, Vídeňská 1958/9, Prague 4 140 21, Czechia.
- First Faculty of Medicine, Charles University, Kateřinská 1660/32, Prague 2 121 08, Czechia.
- Centre for Experimental Medicine, IKEM, Vídeňská 1958/9, Prague 4 140 21, Czechia.
- Department of Data Science, IKEM, Vídeňská 1958/9, Prague 4 140 21, Czechia.
ORCID-Profile: Kristýna Koščálová, Peter Novodvorský, Iva Jakubíková, Adam Ševčík, Iveta Pleyerová, Jakub Štoček, Helena Kratochvílová, Luděk Horváth, Miloš Mráz, Jan Mareš, Dan Wichterle, Josef Kautzner, Martin Haluzík
Förderung
- Agency for Health Research
- Ministry of Health of the Czech Republic
Zitieren
APA
Koščálová, K., Novodvorský, P., Jakubíková, I., Ševčík, A., Rafaj, A., Pleyerová, I., Heidu, K., Štoček, J., Kratochvílová, H., Horváth, L., Mráz, M., Mareš, J., Wichterle, D., Kautzner, J., & Haluzík, M. (2026). A randomized comparison of comprehensive weight loss intervention vs. usual care on recurrences of atrial fibrillation in obese patients after catheter ablation: HOBIT-AF trial. Europace, 28(11). https://doi.org/10.1093/europace/euag178
Vancouver
Koščálová K, Novodvorský P, Jakubíková I, Ševčík A, Rafaj A, Pleyerová I, et al. A randomized comparison of comprehensive weight loss intervention vs. usual care on recurrences of atrial fibrillation in obese patients after catheter ablation: HOBIT-AF trial. Europace. 2026;28(11). doi:10.1093/europace/euag178
BibTeX
@article{Kolov2026,
author = {Koščálová, Kristýna and Novodvorský, Peter and Jakubíková, Iva and Ševčík, Adam and Rafaj, Adam and Pleyerová, Iveta and Heidu, Kristýna and Štoček, Jakub and Kratochvílová, Helena and Horváth, Luděk and Mráz, Miloš and Mareš, Jan and Wichterle, Dan and Kautzner, Josef and Haluzík, Martin},
title = {A randomized comparison of comprehensive weight loss intervention vs. usual care on recurrences of atrial fibrillation in obese patients after catheter ablation: HOBIT-AF trial},
journal = {Europace},
year = {2026},
volume = {28},
number = {11},
doi = {10.1093/europace/euag178}
}
EUVIMED